As President Trump's April 2nd “Liberation Day” approaches, the stock market has been selling off due to uncertainties on the impact of the tariff policy implementation intended to even out the presently skewed international playing field.
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE:UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own share...
NEW YORK , March 29, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own shares of Un...
UnitedHealth Group continues to deliver sector-crushing dividend growth to its shareholders. The company's revenue and adjusted diluted EPS climbed higher in the fourth quarter. UnitedHealth Group maintains strong financials.
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE:UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own share...
UnitedHealth Group has shown unparalleled resiliency, growing adjusted earnings by over 10% despite facing significant headwinds, making it a 'Buy' at historical lows. The company endured a tough period with regulatory scrutiny, higher utilization rates, a cyberattack, and the tragic shooting of a key executive. Q4 marked a bottom for growth and profitability, with revenues of $101 billion and ...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.